Trials / Sponsors / Eledon Pharmaceuticals
Eledon Pharmaceuticals
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients Kidney Transplant Rejection | Phase 2 | 2023-10-25 |
| Completed | Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation Kidney Transplant Rejection | Phase 2 | 2023-08-30 |
| Withdrawn | Safety, Tolerability, and Efficacy of Immunomodulation With AT-1501 in Combination With Transplanted Islet Cel Brittle Type 1 Diabetes Mellitus | Phase 1 / Phase 2 | 2022-09-30 |
| Terminated | Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN) IgA Nephropathy, IgAN | Phase 2 | 2022-03-21 |
| Recruiting | Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant Prevention of Rejection in Kidney Transplant | Phase 1 / Phase 2 | 2022-02-18 |